http://www.fpnotebook.com/
Triphasil
- See Also
- Preparations (Levonorgestrel / Ethinyl Estradiol)
- Triphasil (0.05/30 - 0.075/40 - 0.125/30)
- Components
- Levonorgestrel 0.05 to 0.125 mg (see preparation above)
- Ethinyl Estradiol 30 to 40 ug
- Effect
- Relative Progestational Activity: 0.5 (low)
- Estrogenic Activity: 28 (moderate)
- Androgenic Activity: 0.29 (moderate)
- Pill associated problems (Similar to Ortho-Novum 7/7/7)
- Indications to switch to Ortho Cyclen
- Acne Vulgaris (lower androgen)
- Increased Appetite (lower Progestin)
- Major Depression provoked (lower Progestin)
- Indications to switch to Demulen 1/35
- Indications to switch to Modicon
- Indications to switch to Lo/Ovral
- Libido decreased (more androgen)
- Indications to switch to Ortho Novum 1/35
- Break-through bleed days 10-21 (more Progestin)
- Heavy Menses (more Progestin or less Estrogen)
- Dysmenorrhea or Menstrual Cramps (more Progestin)
- Indications to switch to Ortho Cyclen
- References
- Cerel-Suhl (1999) Am Fam Physician 60(7):2073
- Speroff (1993) Obstet Gynecol 81:1034
- Dickey (1998) Managing Contraceptive Pill Patients
Triphasil (C0728965) | |
|---|---|
| Concepts | Steroid (T110) , Pharmacologic Substance (T121) , Hormone (T125) |
| MSH | D019304 |
| English | Triphasil |
| Sources | MSH Derived from the NIH UMLS (Unified Medical Language System) |